Biotech Startups
11,050 companies tagged Biotech, with their investors and founders.
AmideBio discovers and designs peptide therapeutics for metabolic diseases, using in-silico design and its BioPure process to produce ultrapure peptides. It also sells manufactured peptides and offers custom synthesis services to the biopharmaceutical industry and research community, aiming to license drug candidates at or before the IND stage.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
AMPEL BioSolutions develops RNA-based precision medicine products using its AMPEL Genomic Platform (AGP), which combines RNA analytics and predictive AI to evaluate disease status, identify cellular functions and pathways, and predict disease flares and drug targets from blood and biopsy tests. Its clinical products, such as LuGENE, DermaGENE, and WellGENE, support genomic diagnostics for patient disease management.
0 investors
Amphix Bio develops peptide therapeutics based on a supramolecular chemistry platform that forms nanostructure scaffolds to activate regenerative signaling in cells and tissues. Its pipeline targets neurological injuries, neuro-inflammatory diseases, and musculoskeletal disorders.
0 investors
0 investors
0 investors
0 investors
Armata is a pharmaceutical company developing phage-based therapeutics to treat antibiotic-resistant bacterial infections. It focuses on addressing the global challenge of antibiotic resistance.
0 investors
0 investors
Amydis develops proprietary ocular tracers that detect molecular biomarkers for diseases of the eye, heart, and brain through non-invasive eye-based testing. It builds a multi-omics data warehouse and AI-enabled health insights to support earlier diagnosis and precision treatment.
0 investors
0 investors
Ananda Scientific develops investigational CBD-based drugs delivered in soft gelatin capsules, with its Nantheia A1002N5S product formulated for rapid gastrointestinal absorption. The company is running FDA-approved clinical trials targeting PTSD, Social Anxiety Disorder, and radiculopathic pain, focusing on treatments for neuropsychiatric disorders.
0 investors
0 investors
0 investors
0 investors
ANDE develops Rapid DNA technology, providing mobile and ruggedized systems that let field teams perform DNA analysis on-site. The equipment is designed for rapid integration of DNA testing into operational workflows outside of traditional laboratory settings.
0 investors
0 investors
0 investors
0 investors
0 investors

